AstraZeneca PLC

AZN: XLON (GBR)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|dy?LOCK|Q@LOCK|w%$gWXpm

AstraZeneca: Drug Pricing Agreement Mitigates Threats of Tariffs and Price Controls

On Oct. 10, 2025, AstraZeneca and the US government announced an agreement on US drug pricing. In return, the US agreed to delay the implementation of Section 232 tariffs for three years. Astra is the second drugmaker to announce a deal after Pfizer.

Sponsor Center